论文部分内容阅读
国药一心制药有限公司是中国医药集团下属的子公司,是高新技术企业、国内首批GMP认证企业之一。公司注册资金1亿元,占地面积10万平方米。公司将在2年内投资2亿元用于新建符合欧盟认证标;隹的固体制剂车间及注射制剂车间。公司生产的多种抗肿瘤产品及药品获国内多项专利(专利号:ZL 03 137070.5:专利号:ZL 2004 1 0010833.2),已成为国内抗肿瘤医药领域的先锋。为不断开拓进取,我公司已经与
Sinopharm Medicine Co., Ltd. is a subsidiary of China National Pharmaceutical Group, a high-tech enterprise and one of the first batch of GMP certified enterprises in China. Companies registered capital of 100 million yuan, covers an area of 100,000 square meters. The company will invest 200 million yuan in 2 years for the new EU-certified standard; 隹 solid preparation workshop and injection preparation workshop. A variety of anti-tumor products and pharmaceutical companies by the domestic number of patents (Patent No .: ZL 03 137070.5: Patent No .: ZL 2004 1 0010833.2), has become the pioneer in the field of anti-cancer medicine. In order to continuously forge ahead, our company has been with